Corporate Controller
Pubblicato il 29-08-2026 - Macchinari e impiantistica in Roma
Zambon is a multinational chemical-pharmaceutical company founded on the history and values of an Italian family. Based on a valuable heritage but strongly focused on the future, its Purpose is “Advancing Cure with Care, Opening Health to Life Possibilities”. Zambon operates in three different Continents – Europe, America and Asia – with more than 2,700 employees and manufacturing units in Italy, Switzerland, France, China and Brazil. Zambon products are commercialized in 87 countries. Alongside the three historical therapeutic areas - diseases of the respiratory system, urinary tract infections and pain treatment – Zambon is focused on developing treatments for neurodegenerative diseases such as Parkinson's or rare diseases such as cystic fibrosis and BOS (Bronchiolitis Obliterans Syndrome).
Non aspetti a candidarsi dopo aver letto questa descrizione: per questa possibilità è previsto un elevato volume di candidature.
The Role:
Reporting to the Group Industrial Controlling Director, the Corporate Controller will help to deliver world-class expertise,
providing a solid financial supervision of the Global footprint.
Main Responsibilities of the role:
Lead the project of implementation of the new Controlling Model (Product Costs, Capex and Stock) coherently with Corporate requirements, which includes a process re-design (SAP upgrade and new EPM design and implementation)
Enhance the current reporting model to allow quicker analysis of the performance
Budget, Forecast and Plans preparation, which includes the capability to identify trends and challenge the figures
Delivery of solid variance analysis, providing Business and Finance stakeholders with adequate information to put in place actions to improve P&L; and cash flow performance
Business Case implementation and Make versus Buy analysis
Business partnership with Corporate and local leaders, providing guidance on financials and follow-ups on actions undertaken to assess the effectiveness on P&L;
What we are looking fo